| 标题 |
A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Andrew W. Hahn; Jad Chahoud; William Paul Skelton; Ying Yuan; Amado J. Zurita; et al 出版日期:2025-10-18 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)